BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 30361285)

  • 1. Continuous Microbiological Environmental Monitoring for Process Understanding and Reduced Interventions in Aseptic Manufacturing.
    Weber J; Hauschild J; Ijzerman-Boon P; Forng RY; Horsch J; Yan L; Prasad A; Henry RB; Claassen M; Villari P; Shereefa S; Wyatt J; Bolden JS; Pycke JT; Dassu D
    PDA J Pharm Sci Technol; 2019; 73(2):121-134. PubMed ID: 30361285
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the BioVigilant IMD-A, a novel optical spectroscopy technology for the continuous and real-time environmental monitoring of viable and nonviable particles. Part II. Case studies in environmental monitoring during aseptic filling, intervention assessments, and glove integrity testing in manufacturing isolators.
    Miller MJ; Walsh MR; Shrake JL; Dukes RE; Hill DB
    PDA J Pharm Sci Technol; 2009; 63(3):259-83. PubMed ID: 20069799
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Charting and Evaluation of Environmental Microbial Monitoring Data.
    Bar R
    PDA J Pharm Sci Technol; 2015; 69(6):743-61. PubMed ID: 26659105
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of different incubation conditions for microbiological environmental monitoring.
    Gordon O; Berchtold M; Staerk A; Roesti D
    PDA J Pharm Sci Technol; 2014; 68(5):394-406. PubMed ID: 25336415
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Practical Applications of Biofluorescent Particle Counting in Environmental Monitoring Investigations.
    Prasad A; Milling A; Hauschild J; Ruh AC; Horsch J; Weber J; Yan L; Plourde L; Claassen M; Villari P; IJzerman-Boon P; Forng RY; Henry RB; Portmann R; Shereefa S; Urwyler S; Dassu D
    PDA J Pharm Sci Technol; 2020; 74(3):318-323. PubMed ID: 31843986
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Continuous and Effective Microbiological Air Monitoring in Critical Environments: A Comparison of Analytical Methodologies.
    Dalmaso G; Campanella A; Lazzeri P
    PDA J Pharm Sci Technol; 2020; 74(4):446-455. PubMed ID: 32060221
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Continuous microbiological air monitoring for aseptic filling lines.
    Ginsbury K
    PDA J Pharm Sci Technol; 2007; 61(4):225. PubMed ID: 17933205
    [No Abstract]   [Full Text] [Related]  

  • 8. Continuous microbiological air monitoring for aseptic filling lines.
    Scherwing C; Golin F; Guenec O; Pflanz K; Dalmaso G; Bini M; Andone F
    PDA J Pharm Sci Technol; 2007; 61(2):102-9. PubMed ID: 17479718
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Active air vs. passive air (settle plate) monitoring in routine environmental monitoring programs.
    Andon BM
    PDA J Pharm Sci Technol; 2006; 60(6):350-5. PubMed ID: 17260900
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multicenter Study on Incubation Conditions for Environmental Monitoring and Aseptic Process Simulation.
    Guinet R; Berthoumieu N; Dutot P; Triquet J; Ratajczak M; Thibaudon M; Bechaud P; Arliaud C; Miclet E; Giordano F; Larcon M; Arthaud C
    PDA J Pharm Sci Technol; 2017 1/2; 71(1):43-49. PubMed ID: 27593691
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the BioVigilant IMD-A, a novel optical spectroscopy technology for the continuous and real-time environmental monitoring of viable and nonviable particles. Part I. Review of the technology and comparative studies with conventional methods.
    Miller MJ; Lindsay H; Valverde-Ventura R; O'Conner MJ
    PDA J Pharm Sci Technol; 2009; 63(3):245-58. PubMed ID: 20069798
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Control systems engineering in continuous pharmaceutical manufacturing. May 20-21, 2014 Continuous Manufacturing Symposium.
    Myerson AS; Krumme M; Nasr M; Thomas H; Braatz RD
    J Pharm Sci; 2015 Mar; 104(3):832-9. PubMed ID: 25546650
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Revision of Viable Environmental Monitoring in a Development Pilot Plant Based on Quality Risk Assessment: A Case Study.
    Ziegler I; Borbély-Jakab J; Sugó L; Kovács RJ
    PDA J Pharm Sci Technol; 2017; 71(3):234-244. PubMed ID: 28089966
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Points to Consider: Best Practices to Identify Particle Entry Routes along the Manufacturing Process for Parenteral Formulations.
    Anger S; Begat C; Crnko V; Fantozzi G; Farach W; Fitzpatrick S; Gallagher B; Huelsmann S; Kinsey P; Langlade V; Lefevre G; Legendre E; McLean K; Miller J; Patel R; Perry A; Soukiassian H; Stanton A; Streich D; Timmons C; Vaneylen D; van Hoose T; Wildling L; Windover M
    PDA J Pharm Sci Technol; 2019; 73(6):635-647. PubMed ID: 31420504
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Application of rapid microbiological methods for the risk assessment of controlled biopharmaceutical environments.
    Sandle T; Leavy C; Jindal H; Rhodes R
    J Appl Microbiol; 2014 Jun; 116(6):1495-505. PubMed ID: 24575809
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biopharmaceutical Industry Approaches to Facility Segregation for Viral Safety: An Effort from the Consortium on Adventitious Agent Contamination in Biomanufacturing.
    Barone PW; Avgerinos S; Ballard R; Brussel A; Clark P; Dowd C; Gerentes L; Hart I; Keumurian FJ; Kindermann J; Leung JC; Ly N; Mink S; Minning S; Mullberg J; Murphy M; Nöske K; Parriott S; Shum B; Wiebe ME; Springs SL
    PDA J Pharm Sci Technol; 2019; 73(2):191-203. PubMed ID: 30361281
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In support of settle plates.
    Whyte W
    PDA J Pharm Sci Technol; 1996; 50(4):201-4. PubMed ID: 8810833
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Investigation of the detection ability of an intrinsic fluorescence-based bioaerosol detection system for heat-stressed bacteria.
    Irie K; Scott A; Hasegawa N
    PDA J Pharm Sci Technol; 2014; 68(5):478-93. PubMed ID: 25336419
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quality Control Testing for Tracking Endotoxin-Producing Gram-Negative Bacteria during the Preparation of Polyvalent Snake Antivenom Immunoglobulin.
    Sheraba NS; Diab MR; Yassin AS; Amin MA; Zedan HH
    PDA J Pharm Sci Technol; 2015; 69(4):499-510. PubMed ID: 26242786
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Validation Study of Rapid Assays of Bioburden, Endotoxins and Other Contamination.
    Shintani H
    Biocontrol Sci; 2016; 21(2):63-72. PubMed ID: 27350424
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.